Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Inovio Pharmaceuticals Inc. closed 86.91% short of its 52-week high of $14.75, which the company reached on April 1st.
Nature5y
Neurodevelopmental and Respiratory Outcomes at 2 Years of Age in Preterm Infants Treated with Inhaled Nitric Oxide: the Euno Trial Follow Up
Methods: Babies < 29 weeks of gestation with moderate respiratory failure in the first 24 hours after birth were randomly allocated iNO 5 ppm for 7 to 21 days or placebo gas. All babies were ...
The Motley Fool29d
Inovio Pharmaceuticals (NASDAQ: INO)
Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...